An underwhelming earnings report and ongoing questions about increasing competition in the booming obesity medicine field sent Novo Nordisk’s shares down Wednesday.

Shifting from topic to topic, with few connections, is one of several disjointed and occasionally incoherent verbal habits that seem to have increased in Trump’s speech.

Pharma leaders have dual missions: advancing health and being responsible to shareholders. They must be held accountable for executing effective strategies for both.

Chronic pain and its unequal treatment need to be acknowledged as a public health problem, a health disparities priority, a civil rights infringement, and a human rights violation.

This is the second in a periodic series from STAT about how UnitedHealth Group wields its unrivaled physician empire to boost profits and expand its influence.

Walz extended an emergency stay-at-home order which lasted through mid-May — prompting then-president Trump to declare ...

Walz backed down in a high-profile showdown with the Mayo Clinic last year over two bills. The behemoth had threatened to ...

Roche abruptly canceled a Phase 2 trial of a drug studied in children with Dup15q syndrome, a rare genetic disorder ...

A rie Belldegrun has yet another job: He wants to be your lender.